Physician profile
Lisa Dabney
NPI 1578564266
$2,048.48
in general payments reported to CMS, 2019-2025
10 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $352 · 2020: $158 · 2021: $206 · 2022: $208 · 2023: $606 · 2024: $417 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,124.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,010.82 | 2019-2024 | Altis |
| Axonics, INC. | $249.54 | 2023 | Bulkamid, Axonics |
| Boston Scientific Corporation | $175.00 | 2024 | |
| Escala Medical INC. | $167.76 | 2024 | |
| Medtronic, INC. | $145.02 | 2023 | Interstim |
| Caldera Medical, INC | $101.91 | 2025 | |
| Abbvie INC. | $89.37 | 2022-2023 | Botox |
| Applied Medical Resources Corporation | $71.35 | 2023 | |
| Amag Pharmaceuticals, INC. | $20.95 | 2019 | |
| Hologic Sales and Service, LLC | $16.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Dabney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.